OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
12.06
-0.04 (-0.33%)
May 31, 2024, 4:00 PM EDT - Market closed
OptimizeRx Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for OptimizeRx stock have an average target of 16, with a low estimate of 13 and a high estimate of 20. The average target predicts an increase of 32.67% from the current stock price of 12.06.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OptimizeRx stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +32.67% | May 15, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +7.79% | May 15, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +24.38% | Apr 16, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $15 | Buy | Initiates | $15 | +24.38% | Apr 4, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +7.79% | Apr 1, 2024 |
Financial Forecast
Revenue This Year
103.50M
from 71.52M
Increased by 44.71%
Revenue Next Year
115.30M
from 103.50M
Increased by 11.40%
EPS This Year
0.31
from -1.03
EPS Next Year
0.49
from 0.31
Increased by 61.71%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 109.2M | 122.2M | 133.4M |
| Avg | 103.5M | 115.3M | 129.5M |
| Low | 98.1M | 107.9M | 124.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 52.7% | 18.1% | 15.7% |
| Avg | 44.7% | 11.4% | 12.4% |
| Low | 37.1% | 4.2% | 7.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.37 | 0.61 | 0.80 |
| Avg | 0.31 | 0.49 | 0.78 |
| Low | 0.25 | 0.42 | 0.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 99.2% | 61.4% |
| Avg | - | 61.7% | 56.8% |
| Low | - | 37.8% | 50.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.